Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876. WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells (Cancers, (2021), 13, 15, (3876), 10.3390/cancers13153876)

In the original publication [1], funding from the Iraqi Ministry of Higher Education and Scientific Research to Ahmed Khairallah Mahdi was not included. Ahmed Khairallah Mahdi was not included as an author in the original publication. The corrected Author Contributions statement appears here. Author Contributions: Conceptualization, C.-E.W., A.K.M., C.-Y.H., C.-N.Y. and J.L.; Data curation, C.-E.W. and C.-P.C.; Formal analysis, C.-P.C. and Y.-R.P.; Funding acquisition, C.-E.W. and C.-N.Y.; Investigation, C.-P.C., Y.-R.P., J.W.-C.C. and J.-S.C.; Methodology, C.-E.W., A.K.M., C.-Y.H. and Y.-R.P.; Project administration, C.-E.W.; Supervision, J.L.; Validation, C.-E.W., C.-Y.H., C.-N.Y. and J.L.; Visualization, C.-P.C.; Writing—Original draft, C.-E.W.; Writing—Review and editing, C.-N.Y. and J.L. All authors have read and agreed to the published version of the manuscript. Ahmed Khairallah Mahdi and Chiao-En Wu have equally contributed to the initiation, conceptualization and methodology of the study. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.